Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
10.9M
-
Shares change
-
-286K
-
Total reported value, excl. options
-
$17.9M
-
Value change
-
-$500K
-
Number of buys
-
3
-
Number of sells
-
-17
-
Price
-
$1.64
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q1 2024
26 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q1 2024.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.9M shares
of 130M outstanding shares and own 8.36% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (10.3M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (260K shares), Bank of New York Mellon Corp (124K shares), AMUNDI (78.2K shares), JPMORGAN CHASE & CO (20.8K shares), Voya Investment Management LLC (17.5K shares), NEW YORK STATE COMMON RETIREMENT FUND (17.2K shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.5K shares), CITADEL ADVISORS LLC (6.1K shares), and Legal & General Group Plc (4.01K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.